Insiders Sell, Investors Watch: What’s Going On at PG?

Over the last year, the share price of Procter & Gamble (PG:NYSE) has fallen from around $175 to roughly $140, with most of the decline occurring since March. This weakness may partly reflect layoffs announced earlier in the year amid tariff-related uncertainty, and the stock may now be drifting into oversold territory. Simply Wall St places fair value at the upper end of the range at $185.05. Using my own valuation approach—primarily expected-return and discounted-cash-flow methods—fair value appears closer to the $150 per-share area, though this naturally depends on the assumptions embedded in my model.

PG’s current P/E ratio of about 20× also looks modest for a company with its brand strength and earnings consistency.

Insider activity is worth noting. Over the past six months, particularly in August and October, insiders have been consistent sellers. Simply Wall St reports 21 separate insider sales and no insider purchases during this period. It’s unclear what is driving this behaviour, and the volume of selling seems higher than one would expect from routine portfolio adjustments or short-term liquidity needs. For a company with PG’s blue-chip reputation, the pattern is unusual.

The company maintains a powerful stable of global brands. Originally a 19th-century soap and candle maker, PG now owns household names such as Metamucil, Tampax, Pampers, Braun, Gillette, Pantene, Ambi-Pur, Vicks, Oral-B, Clearblue, Olay, and Old Spice—non-food consumer staples with strong brand loyalty and frequent repeat purchases.

Financially, the business remains robust. PG operates with a gross margin around 50% and a net margin near 18–19%, indicating an efficient operation with significant safety buffers should consumer behaviour shift. Sudden large-scale changes in shaving, hygiene, dental, or personal-care spending seem unlikely, and PG’s global footprint provides resilience across regions and economic cycles.

While PG is not a high-growth story, it has demonstrated a willingness to expand through acquisition where brand fit is strong. It also remains highly active in product development: according to the latest WIPO World Intellectual Property Indicators, Procter & Gamble was one of the world’s leading filers of industrial design applications, ranking among the top companies globally. This suggests a genuinely active and well-resourced R&D engine.

Debt is towards the higher end, with a debt-to-equity ratio of roughly 67%, but the interest-coverage ratio of about 51× indicates the obligations are comfortably managed. Most of PG’s products are non-discretionary, meaning demand typically holds up even in downturns.

Despite the broader rise in US equities, PG appears to be entering oversold territory, and a relatively quick 10% rebound would not be surprising. Still, the insider selling and the downward trend in the share price are worth monitoring.

This is one for the watchlist. A stabilising share price—or insiders returning as net buyers—could signal a short-term recovery. If neither occurs, we may soon hear more about what’s happening internally at the company.